Mark DeLuca specializes in organic chemistry and chemical processes. He serves as a Registered Patent Agent. While an undergraduate, Dr. DeLuca performed research studying the synthesis and properties of charge separated heterocyclic compounds. Dr. DeLuca received the award for best undergraduate thesis in chemistry for this work.
His Ph.D. research was involved with the synthesis of complex natural products. During this research Dr. DeLuca was involved in the completion of the total synthesis of the natural products: koumine, strychnine, and UK-1. After completion of his Ph.D., Dr. DeLuca worked as a Research Associate in the Department of Medicinal Chemistry at the University of Texas at Austin. In this position, Dr. DeLuca’s research involved the synthesis and analysis of novel heterocyclic compounds for use in the treatment of cancer and osteoporosis. Dr. DeLuca is the author and co-author of eleven publications which have appeared in various chemical journals. Dr. DeLuca is a member of the American Chemical Society.